Long-chain ω-halofatty acids, especially ω-123I-iodoheptadecanoic acid (IHA), are widely used clinically as radiopharmaceuticals for functional heart imaging. The metabolic interpretation of the various elimination rates, however, remains in dispute. It has been previously shown (Kloster and Stöcklin 1982) that in isolated perfused guinea-pig hearts halide diffusion from the mitochondrion to the blood is the rate-determining step of IHA pharmacokinetics in normal myocardium. We have now extended these in vitro experiments to normal and globally ischaemic isolated perfused rabbit hearts. Again, in normal hearts a single phase iodide elimination half-time (14.3±2.1 min) was observed. In hearts made globally ischaemic for 90 min, the iodide elimination was biphasic with a first fast phase (T1/2=3.8±0.49 min) and a late slow phase (T 1/2=60.5±14.0 min). The first fast phase is attributed to iodide ion released by residual β-oxidation (more rapid than in normal hearts due to damaged membranes in ischaemia), while the late slow phase is explained by β-oxidation of IHA slowly released by hydrolysis of intracellular lipid stores. These data were compared with published data from investigations in patients which seem to support our interpretation.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Bing RJ, Siegel A, Ungar J, Gilbert M (1954) Metabolism of the human heart. Am J Med 16:504–515
Bretschneider HJ, Hübner G, Knoll D, Lohr B, Nordbeck H, Spieckermann PG (1975) Myocardial resistance and tolerance to ischemia: Physiological and biochemical basis. J Cardiovasc Surg 16:241–260
Dudczak R, Kletter K, Frischauf H, Schmoliner R, Derfler K, Losert U (1982) Myocardial turnover rates of I-123 heptadecanoic acid (HDA) and I-123 p-phenylpentadecanoic acid (pIPPA). Radioakt Isotope Klin Forsch 15:685–694
Egge H, Murawski U, Müller J, Zilliken F (1970) Mikrolipidanalysen aus Serum mit dem Eppendorfsystem 3000. Z Klin Chem Klin Biochem 8:488–491
Evans JR, Gunton RW, Baker RG, Beanlands DS, Spears JC (1965) Use of radioiodinated fatty acid for photoscans of the heart. Circ Res 16:1–10
Feinendegen LE, Shreeve WW (1983) On behalf of I-123 fatty acids for myocardial metabolic imaging. J Nucl Med 24:545–546
Freundlieb C, Höck A, Vyska K, Feinendegen LE, Machulla HJ, Stöcklin G (1980) Myocardial imaging and metabolic studies with [17-123I]iodoheptadecanoic acid. J Nucl Med 21:1043–1050
Gatley SJ, Halama JR, Holden JE, DeGrado T, Shug AL (1983) On the rate-limiting step in myocardial clearance of label from 16-iodohexadecanoic acid (IHDA). J Nucl Med 24:P12 (abstr.)
Goldstein RA (1983) Reply [to Feinendegen and Shreeve]. J Nucl Med 24:546
Henze E, Grossman RG, Huang SC, Barrio JR, Phelps ME, Schelbert HR (1982) Myocardial uptake and clearance of C-11 palmitic acid in man: Effects of substrate availability and cardiac work. J Nucl Med 23:P12-P13 (abstr.)
Höck A, Freundlieb C, Vyska K, Lösse B, Erbel R, Feinendegen LE (1983) Myocardial imaging and metabolic studies with [17-123I] iodoheptadecanoic acid in patients with idiopathic congestive cardiomyopathy. J Nucl Med 24:22–28
Klein MS, Goldstein RA, Welch MJ, Sobel BE (1979) External assessment of myocardial metabolism with [11C] palmitate in rabbit hearts. Am J Physiol 237:H51-H57
Kloster G, Stöcklin G (1982) Determination of the rate-determining step in halofatty acid turnover in the heart. Radioakt Isotope Klin Forsch 15:235–241
Knust EJ, Kupfernagel C, Stöcklin G (1979) Long-chain F-18 fatty acids for the study of regional metabolism in heart and liver; odd-even effects of metabolism in mice. J Nucl Med 20:1170–1175
Kupfernagel C (1978) Qualitätskontrolle und Pharmakokinetik 11C-, 18F, 34mCl-, 77Br- und 123I-markierter Fettsäuren. Ph D Thesis, Jül-1551-NC
Laufer P, Machulla HJ, Michael H, Coenen HH, El-Wetery AS, Kloster G, Stöcklin G (1981) Preparation of ω-123I-labelled fatty acids by 123I-for-Br exchange: Comparison of three methods. J Labelled Comp Radiopharm 18:1205–1214
Machulla HJ, Stöcklin G, Kupfernagel C, Freundlieb C, Höck A, Vyska K, Feinendegen LE (1978) Comparative evaluation of fatty acids labeled with C-11, Cl-34m, Br-77, and I-123 for metabolic studies of the myocardium: concise communication. J Nucl Med 19:298–302
Okada RD, Elmaleh D, Werre GS, Strauss HW (1983) Myocardial kinetics of 123I-labeled-16-hexadecanoic acid. Eur J Nucl Med 8:211–217
Rösler H, Hess T, Weiss M, Noelpp U, Müller G, Hoeflin F, Kinser J (1983) Tomoscintigraphic assessment of myocardial metabolic heterogeneity. J Nucl Med 24:285–296
Salvatore G, Salvatore M, Wolff J (1966) Restriction of cellular iodide space by mediated efflux. Biochim Biophys Acta 120:383–394
Smith III EF, Kloster G, Schrör K, Stöcklin G (1983) Radioiodinated ω-halofatty acids: A probe for myocardial membrane integrity. J Mol Cell Cardiol 15 (Suppl 1): 289 (abstr)
Tosteson DC (1959) Halide transport in red blood cells. Acta Physiol Scand 46:19–41
van der Wall EE, den Hollander W, Heidendal GAK, Westera G, Majid PA, Roos JP (1981a) Dynamic myocardial scintigraphy with 123I-labeled free fatty acids in patients with myocardial infarction. Eur J Nucl Med 6:383–389
van der Wall EE, Heidendal GAK, den Hollander W, Westera G, Roos JP (1981b) Metabolic myocardial imaging with 123I-labeled heptadecanoic acid in patients with angina pectoris. Eur J Nucl Med 6:391–396
Weiss ES, Hoffman EJ, Phelps ME, Welch MJ, Henry PD, TerPogossian MM, Sobel BE (1976) External detection and visualization of myocardial ischemia with 11C-substrates in vitro and in vivo. Circ Res 39:24–32
About this article
Cite this article
Kloster, G., Stöcklin, G., Smith, E.F. et al. ω-Halofatty acids: A probe for mitochondrial membrane integrity. Eur J Nucl Med 9, 305–311 (1984). https://doi.org/10.1007/BF00276459
- Normal Heart
- Lipid Store
- Rabbit Heart
- Intracellular Lipid